BioMarin Pharmaceuticals Inc BMRN
$63.94
-1.75%
at last close
Financials (TTM)
- Revenue
- $3.41 billion
- Net Income
- $72.97 million
- Net Margin
- 2.14%
- Return on Equity
- 1.15%
- Debt-to-Equity
- 0.66
- P/E Ratio
- 172.81
- Price / Book
- 1.99
- Price / Sales
- 3.70
Over the trailing twelve months, BioMarin Pharmaceuticals Inc generated revenue of $3.41 billion and net income of $72.97 million, a net margin of 2.14%.
At the last closing price of $63.94, BMRN trades at 172.81 times trailing earnings and 3.70 times sales, with a market capitalization of $12.60 billion.
Key Stats
- Last Close
- $63.94
- Market Cap
- $12.60 billion
- 52-Week Range
- $49.26 – $70.98
- Average Volume
- 2.19 million shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.